HomeArticles2022 No.3Details

Risk factors for suicide in patients with pancreatic cancer using data from the SEER database

Update:Jan. 22, 2022Total Views:1360Total Downloads:1213 DownloadMobile

Author: HUANG Liying HUANG Tao LI Li FENG Aozi HE Ningxia LI Shuna LYU Jun

Affiliation: Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China

Keywords: Pancreatic cancer Suicide SEER Risk factors

DOI:10.12173/j.issn.1004-5511.202109009

Reference:Huang LY, Huang T, Li L, Feng AX, He NX, Li SN, Lyu J. Risk factors for suicide in patients with pancreatic cancer using data from the SEER database[J]. Yixue Xinzhi Zazhi, 2022, 32(3): 192-200. DOI: 10.12173/j.issn.1004-5511.202109009.[Article in Chinese]

  • Abstract
  • Full-text
  • Figures and Tables
  • References
Abstract

Objective  To explore risk factors for suicide in patients with pancreatic cancer. 

Methods  The SEER Research Plus database (Surveillance, Epidemiology, and End Results) was searched from 1975 to 2018 for patients with pancreatic cancer. The characteristics and distribution of suicidal and non-suicidal death and cancer survivors were described. The person-year mortality rate from suicide and standard mortality ratio were calculated to analyze characteristics of corresponding groups. Regression analysis was used to investigate risk factors for suicide in patients with pancreatic cancer, with further analysis of male patients having risk factors associated with suicide. 

Results  The proportions of patients with characteristics of Caucasian (80.68%), up to 65 years old (65.02%), surgery not recommended (70.57%), neoplasm with distant metastasis (57.28%), married (56.06%), median annual household income between 50,000 to 74,999 dollars (47.17%) and no chemotherapy (52.48%) were relatively high in 153,612 patients with pancreatic cancer, which was similar to the stratified population distribution of characteristics of 138 patients with pancreatic cancer who committed suicide. The results of Poisson regression analysis showed that male [aRR=12.81, 95%CI(6.85, 23.96), P<0.001], Caucasian [aRR=3.56, 95%CI (1.43, 8.85), P=0.006], up to 65 years old [aRR=1.55, 95%CI (1.07, 2.26), P=0.022], surgery not recommended [aRR=2.06, 95%CI(1.23, 3.44), P=0.006], surgery recommended but not undertaken [aRR=2.86, 95%CI(1.37, 5.98), P=0.005] had a higher risk of suicide; while tumor regional metastasis [aRR=0.56, 95%CI(0.37, 0.85), P=0.006] and local metastasis [aRR=0.44, 95%CI(0.23, 0.86), P=0.015], married [aRR=0.57, 95%CI(0.40, 0.82), P=0.002], chemotherapy [aRR=0.34, 95%CI(0.23, 0.51), P<0.001] have a relatively low risk of suicide. The suicide risk of male patients with pancreatic cancer is significantly higher than that of female patients. The risk of suicide among male patients with pancreatic cancer showed significant differences between different races, surgical options, marital status, and chemotherapy options. 

Conclusion  Gender, race, age at diagnosis, choice of surgery, SEER stage, marital status and choice of chemotherapy were important risk factors for suicide in patients with pancreatic cancer. Identification, intervention and care need to be promoted among patients with pancreatic cancer having the following characteristics: male, Caucasian, up to 65 years old, surgery either not recommended or recommended but not undertaken, neoplasm with distant metastasis, single status or not having chemotherapy.

Full-text
Please download the PDF version to read the full text: download
References

1.World Health Organization. Suicide worldwide in 2019: global health estimates[EB/OL]. (2021-06-11) [2021-09-08]. https://apps.who.int/iris/handle/10665/341728.

2.Yu R, Chen Y, Li L, et al. Factors associated with suicide risk among Chinese adults: a prospective cohort study of 0.5 million individuals[J]. PLoS Med, 2021, 18(3): e1003545. DOI: 10.1371/journal.pmed.1003545.

3.Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33. DOI: 10.332 2/caac.21654.

4.Sung H, Ferlay J, Siegel R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.

5.Zaorsky NG, Zhang Y, Tuanquin L, et al. Suicide among cancer patients[J]. Nat Commun, 2019, 10(1): 207. DOI: 10.1038/s41467-018-08170-1.

6.Amiri S, Behnezhad S. Cancer diagnosis and suicide mortality: a systematic review and meta-analysis[J]. Arch Suicide Res, 2019, 24(sup2): S94-S112. DOI: 10.1080/13811118.2019.1596182.

7.Henson KE, Brock R, Charnock J, et al. Risk of suicide after cancer diagnosis in England[J]. JAMA Psychiatry, 2019, 76(1): 51-60. DOI: 10.1001/jamapsychiatry.2018. 3181.

8.Kye SY, Park K. Suicidal ideation and suicidal attempts among adults with chronic diseases: a cross-sectional study[J]. Compr Psychiatry, 2017, 73: 160-167. DOI: 10. 1016/j.comppsych.2016.12.001.

9.Vehling S, Kissane DW, Lo C, et al. The association of demoralization with mental disorders and suicidal ideation in patients with cancer[J]. Cancer, 2017, 123(17): 3394-3401. DOI: 10.1002/cncr.30749.

10.Hovén E, Ljung R, Ljungman G, et al. Increased risk of mental health problems after cancer during adolescence: a register-based cohort study[J]. Int J Cancer, 2020, 147(12): 3349-3360. DOI: 10.1002/ijc.33154.

11.Ji X, Cummings JR, Gilleland Marchak J, et al. Mental health among nonelderly adult cancer survivors: a national estimate[J]. Cancer, 2020, 126(16): 3768-3776. DOI: 10.1002/cncr.32988.

12.Osazuwa-Peters N, Arnold LD, Loux TM, et al. Factors associated with increased risk of suicide among survivors of head and neck cancer: a population-based analysis[J]. Oral Oncol, 2018, 81: 29-34. DOI: 10.1016/j.oraloncology.2018.03.017.

13.McFarland DC, Walsh L, Napolitano S, et al. Suicide in patients with cancer: identifying the risk factors[J]. Oncology (Williston Park), 2019, 33(6): 221-226. https://pubmed.ncbi.nlm.nih.gov/31219606/.

14.Bibok A, Kim DW, Malafa M, et al. Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer[J]. World J Gastroenterol, 2021, 27(27): 4322-4341. DOI: 10.3748/wjg.v27.i27.4322.

15.Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017[J]. Acta Oncol, 2016, 55(9-10): 1158-1160. DOI: 10.1080/0284186X.2016.1197419.

16.Du L, Shi HY, Yu HR, et al. Incidence of suicide death in patients with cancer: a systematic review and meta-analysis[J]. J Affect Disord, 2020, 276: 711-719. DOI: 10.1016/j.jad.2020.07.082.

17.Osazuwa-Peters N, Simpson MC, Zhao L, et al. Suicide risk among cancer survivors: head and neck versus other cancers[J]. Cancer, 2018, 124(20): 4072-4079. DOI: 10.1002/cncr.31675.

18.Chen HM, Chen VC, Wang TN, et al. Diseases of the pancreas and suicide mortality: a nationwide nested case-control study among patients with mental health disorders in Taiwan[J]. Gen Hosp Psychiatry, 2018, 50: 45-50. DOI: 10.1016/j.genhosppsych.2017.09.008.

19.Turaga KK, Malafa MP, Jacobsen PB, et al. Suicide in patients with pancreatic cancer[J]. Cancer, 2011, 117(3): 642-647. DOI: 10.1002/cncr.25428.

20.Ailawadhi S, Jagannath S, Narang M, et al. Connect MM registry as a national reference for United States multiple myeloma patients[J]. Cancer Med, 2020, 9(1): 35-42. DOI: 10.1002/cam4.2656.

21.National Cancer Institute. Surveillance, epidemiology, and end results program, SEER incidence data, 1975-2018[EB/OL]. [2021-11-09]. https://seer.cancer.gov/data/.

22.National Cancer Institute. Surveillance, epidemiology, and end results program. Site recode ICD-O-3/WHO 2008 definition[EB/OL]. [2021-11-09]. https://seer.cancer.gov/siterecode/icdo3_dwhoheme/index.html.

23.National Cancer Institute. Surveillance, epidemiology, and end results program. SEER cause of death recode 1969+ (04/16/2012)[EB/OL]. (2012-04-16) [2021-11-09]. https://seer.cancer.gov/codrecode/1969_d04162012/.

24.Centers for Disease Control and Prevention. Fatal injury and violence data[EB/OL]. [2021-11-09]. https://www.cdc.gov/injury/wisqars/fatal.html.

25.Ravaioli A, Crocetti E, Mancini S, et al. Suicide death among cancer patients: new data from northern Italy, systematic review of the last 22 years and meta-analysis[J]. Eur J Cancer, 2020, 125: 104-113. DOI: 10.1016/j.ejca. 2019.08.019.

26.Gauthier JM, Cole AB, Bagge CL. A preliminary examination of the association between drinking as a typical coping strategy and level of acute alcohol consumption prior to a suicide attempt[J]. Psychiatry Res, 2019, 282: 112626. DOI: 10.1016/j.psychres.2019.112626.

27.Jee SH, Kivimaki M, Kang HC, et al. Cardiovascular disease risk factors in relation to suicide mortality in Asia: prospective cohort study of over one million Korean men and women[J]. Eur Heart J, 2011, 32(22): 2773-2780. DOI: 10.1093/eurheartj/ehr229.

28.Yu H, Cai K, Huang Y, et al. Risk factors associated with suicide among leukemia patients: a surveillance, epidemiology, and end results analysis[J]. Cancer Med, 2020, 9(23): 9006-9017. DOI: 10.1002/cam4.3502.

29.Stein EM, Gennuso KP, Ugboaja DC, et al. The epidemic of despair among white Americans: trends in the leading causes of premature death, 1999-2015[J]. Am J Public Health, 2017, 107(10): 1541-1547. DOI: 10.2105/AJPH. 2017.303941.

30.Graetz N, Preston SH, Peele M, et al. Ecological factors associated with suicide mortality among non-Hispanic whites[J]. BMC Public Health, 2020, 20(1): 1339. DOI: 10.1186/s12889-020-09379-w.

31.Wang Z, Yu C, Wang J, et al. Age-period-cohort analysis of suicide mortality by gender among white and black Americans, 1983-2012[J]. Int J Equity Health, 2016, 15(1): 107. DOI: 10.1186/s12939-016-0400-2.

32.Huang J, Lok V, Ngai CH, et al. Worldwide burden of, risk factors for, and trends in pancreatic cancer[J]. Gastroenterology, 2021, 160(3): 744-754. DOI: 10.1053/j. gastro.2020.10.007.

33.Shi S, Yu X. Selecting chemotherapy for pancreatic cancer: far away or so close?[J]. Semin Oncol, 2019, 46(1): 39-47. DOI: 10.1053/j.seminoncol.2018.12.004.

34.Cerullo M, Gani F, Chen SY, et al. Assessing the financial burden associated with treatment options for resectable pancreatic cancer[J]. Ann Surg, 2018, 267(3): 544-551. DOI: 10.1097/SLA.0000000000002069.

35.Du C, Chai NL, Linghu EQ, et al. Endoscopic ultrasound-guided injective ablative treatment of pancreatic cystic neoplasms[J]. World J Gastroenterol, 2020, 26(23): 3213-3224. DOI: 10.3748/wjg.v26.i23.3213.

36.Siri FH, Salehiniya H. Pancreatic cancer in Iran: an epidemiological review[J]. J Gastrointest Cancer, 2020, 51(2): 418-424. DOI: 10.1007/s12029-019-00279-w.

37.Choi J, Lee M, Ki M, et al. Risk factors for feelings of sadness and suicide attempts among cancer survivors in South Korea: findings from nationwide cross-sectional study (KNHANES IV-VI)[J]. BMJ Open, 2017, 7(12): e016130. DOI: 10.1136/bmjopen-2017-016130.

38.Rockett IR, Wang S, Stack S, et al. Race/ethnicity and potential suicide misclassification: window on a minority suicide paradox?[J]. BMC Psychiatry, 2010, 10: 35. DOI: 10.1186/1471-244X-10-35.

Hot Papers